1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA WWC1 CTRPv2 pan-cancer AAC -0.21 4e-06
mRNA LAMA5 CTRPv2 pan-cancer AAC -0.19 1e-05
mRNA EPS8L2 CTRPv2 pan-cancer AAC -0.18 5e-05
mRNA NBR1 CTRPv2 pan-cancer AAC -0.18 5e-06
mRNA DNAJB2 CTRPv2 pan-cancer AAC -0.18 6e-06
mRNA MANBAL CTRPv2 pan-cancer AAC -0.18 0.0002
mRNA TM9SF4 CTRPv2 pan-cancer AAC -0.17 5e-06
mRNA CEP295NL CTRPv2 pan-cancer AAC -0.17 0.0001
mRNA CYTH3 CTRPv2 pan-cancer AAC -0.17 2e-05
mRNA NEDD9 CTRPv2 pan-cancer AAC -0.17 6e-06
Download CSV